Advertisement

Topics

FDA Awards $403k to Help Develop Treatment for Autoimmune-Mediated Condition

05:55 EDT 18 Aug 2017 | PharmPro

Protalex awarded grant from FDA Office of Orphan Products Development to foster clinical development of PRTX-100 for the treatment of immune thrombocytopenia.
Contributed Author: 
Protalex, Inc.

Original Article: FDA Awards $403k to Help Develop Treatment for Autoimmune-Mediated Condition

NEXT ARTICLE

More From BioPortfolio on "FDA Awards $403k to Help Develop Treatment for Autoimmune-Mediated Condition"

Advertisement
Quick Search
Advertisement
Advertisement